全文获取类型
收费全文 | 63762篇 |
免费 | 5475篇 |
国内免费 | 2125篇 |
专业分类
耳鼻咽喉 | 473篇 |
儿科学 | 1360篇 |
妇产科学 | 1582篇 |
基础医学 | 13057篇 |
口腔科学 | 2070篇 |
临床医学 | 4713篇 |
内科学 | 8045篇 |
皮肤病学 | 1771篇 |
神经病学 | 3769篇 |
特种医学 | 1244篇 |
外国民族医学 | 22篇 |
外科学 | 5416篇 |
综合类 | 8729篇 |
一般理论 | 12篇 |
预防医学 | 4150篇 |
眼科学 | 1175篇 |
药学 | 7513篇 |
21篇 | |
中国医学 | 1886篇 |
肿瘤学 | 4354篇 |
出版年
2023年 | 921篇 |
2022年 | 1153篇 |
2021年 | 1926篇 |
2020年 | 1946篇 |
2019年 | 2225篇 |
2018年 | 2139篇 |
2017年 | 2166篇 |
2016年 | 1959篇 |
2015年 | 2178篇 |
2014年 | 3260篇 |
2013年 | 4307篇 |
2012年 | 3362篇 |
2011年 | 3802篇 |
2010年 | 3185篇 |
2009年 | 3055篇 |
2008年 | 2939篇 |
2007年 | 3049篇 |
2006年 | 2916篇 |
2005年 | 2702篇 |
2004年 | 2540篇 |
2003年 | 2208篇 |
2002年 | 1788篇 |
2001年 | 1539篇 |
2000年 | 1386篇 |
1999年 | 1105篇 |
1998年 | 948篇 |
1997年 | 914篇 |
1996年 | 853篇 |
1995年 | 943篇 |
1994年 | 848篇 |
1993年 | 754篇 |
1992年 | 648篇 |
1991年 | 591篇 |
1990年 | 445篇 |
1989年 | 446篇 |
1988年 | 388篇 |
1987年 | 285篇 |
1986年 | 263篇 |
1985年 | 546篇 |
1984年 | 505篇 |
1983年 | 327篇 |
1982年 | 399篇 |
1981年 | 319篇 |
1980年 | 274篇 |
1979年 | 209篇 |
1978年 | 200篇 |
1977年 | 126篇 |
1976年 | 119篇 |
1975年 | 73篇 |
1974年 | 68篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Research in social & administrative pharmacy》2022,18(9):3694-3698
In this paper, we argue that understanding and addressing the problem of poor-quality medical products requires a more interdisciplinary approach than has been evident to date. While prospective studies based on rigorous standardized methodologies are the gold standard for measuring the prevalence of poor-quality medical products and understanding their distribution nationally and internationally, they should be complemented by social science research to unpack the complex set of social, economic, and governance factors that underlie these patterns. In the following sections, we discuss specific examples of prospective quality surveys and of social science studies, highlighting the value of cross-sector partnerships in driving high-quality, policy-relevant research in this area. 相似文献
2.
《Pancreatology》2022,22(8):1175-1180
BackgroundHepatic steatosis has been described as a common finding in adults following total pancreatectomy with islet autotransplantation (TPIAT) but it is unknown if this occurs in children and adolescents.ObjectivesTo define the frequency of post-TPIAT hepatic steatosis in a sample of children and adolescents and to identify clinical predictors of incident steatosis post-TPIAT.MethodsIn this prospective study, consecutive participants at least 1-month post-TPIAT underwent a liver MRI with proton density fat fraction (PDFF) and blood draw at our pediatric academic medical center between April 2021 and January 2022. Comparison clinical pre-TPIAT liver MRI or ultrasound and insulin use and graft function data were extracted from the medical record. T-tests were used for the comparison of means across continuous variables between participants with and without post-TPIAT steatosis.ResultsA total of 20 participants (mean: 13 ± 4 years; 12 female) were evaluated. Mean liver PDFF at research MRI was 7.4 ± 6.2% (range: 2–25%). Seven participants (35%) had categorical hepatic steatosis (PDFF>5%) post-TPIAT, five of whom had pre-TPIAT steatosis, reflecting a 13% (2/15; 95% CI: 2–40%) incidence of post-TPIAT steatosis. Participant characteristics were not significantly different between subgroups with and without post-TPIAT steatosis. Mean PDFF at research MRI was not different between graft function subgroups (7.5% optimal/good vs. 7.3% marginal/failure; p = .96).ConclusionOur study shows a moderate prevalence but low incidence of hepatic steatosis in a small sample of children and adolescents post-TPIAT. This study raises questions about a causal relationship between TPIAT and hepatic steatosis. 相似文献
3.
4.
5.
6.
7.
8.
Laura A. Huppert MD Ozge Gumusay MD Dame Idossa MD Hope S. Rugo MD 《CA: a cancer journal for clinicians》2023,73(5):480-515
Hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer is defined by the presence of the estrogen receptor and/or the progesterone receptor and the absence of HER2 gene amplification. HR-positive/HER2-negative breast cancer accounts for 65%–70% of all breast cancers, and incidence increases with increasing age. Treatment varies by stage, and endocrine therapy is the mainstay of treatment in both early stage and late-stage disease. Combinations with cyclin-dependent kinase 4/6 inhibitors have reduced distant recurrence in the early stage setting and improved overall survival in the metastatic setting. Chemotherapy is used based on stage and tumor biology in the early stage setting and after endocrine resistance for advanced disease. New therapies, including novel endocrine agents and antibody-drug conjugates, are now changing the treatment landscape. With the availability of new treatment options, it is important to define the optimal sequence of treatment to maximize clinical benefit while minimizing toxicity. In this review, the authors first discuss the pathologic and molecular features of HR-positive/HER2-negative breast cancer and mechanisms of endocrine resistance. Then, they discuss current and emerging therapies for both early stage and metastatic HR-positive/HER2-negative breast cancer, including treatment algorithms based on current data. 相似文献
9.
Defects of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) protein affect the homeostasis of chloride, bicarbonate, sodium, and water in the airway surface liquid, influencing the mucus composition and viscosity, which induces a severe condition of infection and inflammation along the whole life of CF patients. The introduction of CFTR modulators, novel drugs directly intervening to rescue the function of CFTR protein, opens a new era of experimental research. The review summarizes the most recent advancements to understand the characteristics of the infective and inflammatory pathology of CF lungs. 相似文献
10.
《Vaccine》2022,40(34):5010-5015
ObjectivesTo investigate the association between providing leaflets to support pediatricians in explaining the safety of the human papillomavirus (HPV) vaccine and mother’s decision to vaccinate their daughters in Japan.MethodsIn this cross-sectional study, we conducted a survey of mothers to evaluate the effect of leaflets that were created to support pediatricians in explaining the safety profile of the HPV vaccine. Mothers who provided consent for vaccination before receiving an explanation were excluded from the study. The primary outcome was the mother’s decision to vaccinate their daughters with the HPV vaccine after receiving an explanation from pediatricians using our leaflets.ResultsAmong 161 eligible mothers, 101 decided on HPV vaccination (decided group) and 60 did not (decided against group). There was no difference in the maternal background between the 2 groups. The decided group had a significantly more positive impression of the leaflets than the undecided group. In multivariable logistic regression analysis, a detailed explanation for possible adverse events and specific solutions to them was associated with the mother's decision to have their daughters vaccinated (odds ratio 2.35, 95% confidence interval 1.02–5.44), but not the pathology of cervical cancer and the HPV vaccination process.ConclusionLeaflets emphasizing an explanation of adverse events may contribute to mothers’ decision making for HPV vaccination. 相似文献